We are live on ! Find out more
Bleichroeder

Bleichroeder Portfolio holdings

AUM $1.02B Turnover 33.63%
1-Year Est. Return 33%
This Fund
S&P 500
This Quarter Est. Return
-3.15%
1 Year Est. Return
+33%
3 Year Est. Return
+222.49%
5 Year Est. Return
+219.92%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$457M
Cap. Flow
+$530M
Cap. Flow %
52.15%
Top 10 Hldgs %
44.01%
Holding
113
New
35
Increased
8
Reduced
7
Closed
3
Avg Time Held
2 years
Top 10 Avg Time Held
2.1 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
PSQL icon
Pasqal Holding SA Ordinary Share
PSQL
+$31.7M
2
MDLN icon
Medline Inc
MDLN
+$18.4M
3
AVGO icon
Broadcom
AVGO
+$17.9M
4
A icon
Agilent Technologies
A
+$17.9M
5
TSM icon
TSMC
TSM
+$17.7M

Top Sells

Rank Stock Value
1
IRD icon
Opus Genetics
IRD
+$2.08M
2
LIN icon
Linde
LIN
+$1.77M
3
OWLT icon
Owlet
OWLT
+$987K
4
FEAM icon
5E Advanced Materials
FEAM
+$638K
5
PYPL icon
PayPal
PYPL
+$220K

Sector Composition

Rank Sector Weight
1 Miscellaneous 23.67%
2 Technology 20.28%
3 Industrials 15.62%
4 Financials 13.79%
5 Healthcare 12.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MCO icon
26
Moody's
MCO
$87.6B
$15.7M 1.54%
+34,556
New +$16.8M
2026 Q3
0 quarters
AWI icon
27
Armstrong World Industries
AWI
$7.35B
$15.6M 1.54%
+96,424
New +$16.2M
2026 Q3
0 quarters
SPOT icon
28
Spotify
SPOT
$126B
$15.5M 1.53%
+31,805
New +$16.2M
2026 Q3
0 quarters
BSY icon
29
Bentley Systems
BSY
$13.4B
$15.2M 1.5%
+475,910
New +$16M
2026 Q3
0 quarters
DUOT icon
30
Duos Technologies
DUOT
$158M
$14.4M 1.42%
1,627,806
– –
2020 Q1
26 quarters
CBRE icon
31
CBRE Group
CBRE
$38.4B
$14.3M 1.41%
+111,240
New +$15.9M
2026 Q3
0 quarters
FERG icon
32
Ferguson
FERG
$49.6B
$14M 1.38%
+62,883
New +$14.6M
2026 Q3
0 quarters
RELX icon
33
RELX
RELX
$70.3B
$13.4M 1.32%
+404,838
New +$14M
2026 Q3
0 quarters
CCC icon
34
CCC Intelligent Solutions
CCC
$4.54B
$13.4M 1.32%
+2,011,941
New +$13.2M
2026 Q3
0 quarters
DTIL icon
35
Precision BioSciences
DTIL
$289M
$12.6M 1.24%
2,018,190
– –
2025 Q1
6 quarters
CME icon
36
CME Group
CME
$114B
$11.2M 1.1%
+42,814
New +$11.3M
2026 Q3
0 quarters
ICE icon
37
Intercontinental Exchange
ICE
$100B
$11M 1.09%
+72,603
New +$11M
2026 Q3
0 quarters
IMMX icon
38
Immix Biopharma
IMMX
$657M
$10.4M 1.02%
1,000,000
– –
2024 Q1
10 quarters
BX icon
39
Blackstone
BX
$95B
$10.2M 1%
90,750
– –
2019 Q4
27 quarters
TCOM icon
40
Trip.com Group
TCOM
$27.4B
$9.7M 0.96%
+249,198
New +$10.7M
2026 Q3
0 quarters
CUE icon
41
Cue Biopharma
CUE
$117M
$9.47M 0.93%
366,152
-4,530
-1% -$134K
2019 Q4
27 quarters
BKNG icon
42
Booking.com
BKNG
$119B
$8.82M 0.87%
+54,171
New +$10.2M
2026 Q3
0 quarters
WELL icon
43
Welltower
WELL
$179B
$6.91M 0.68%
30,000
+10,000
+50% +$2.36M
2025 Q2
5 quarters
INVE icon
44
INVE Technologies, Inc. Common Stock
INVE
$64.5M
$6.81M 0.67%
2,884,495
– –
2019 Q4
27 quarters
ORCL icon
45
Oracle
ORCL
$391B
$5.49M 0.54%
+39,982
New +$5.64M
2026 Q3
0 quarters
IDN icon
46
Intellicheck
IDN
$38M
$4.72M 0.46%
2,056,343
– –
2019 Q4
27 quarters
KZIA icon
47
Kazia Therapeutics
KZIA
$103M
$4.71M 0.46%
490,410
+90,410
+23% +$1.13M
2025 Q4
3 quarters
COCH icon
48
Envoy Medical
COCH
$52.2M
$4.26M 0.42%
625,000
– –
2026 Q1
2 quarters
CGEM icon
49
Cullinan Oncology
CGEM
$667M
$3.84M 0.38%
250,000
– –
2026 Q1
2 quarters
LIQT icon
50
LiqTech
LIQT
$8.7M
$3.65M 0.36%
6,882,239
– –
2020 Q1
26 quarters

Similar funds

Bleichroeder's Q3 2026 Portfolio in Review

As of Q3 2026, Bleichroeder held 113 positions worth $1.02B, up 82% from $559M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Bleichroeder deployed $530M of net new capital in Q3 2026, opening 35 new positions and adding to 8 existing holdings. Its largest new stake was Pasqal Holding SA Ordinary Share: 3,496,313 shares worth $22.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Opus Genetics, an estimated $2.08M trimmed.

  • Bleichroeder's largest Q3 2026 buy was Pasqal Holding SA Ordinary Share: 3,496,313 shares worth $22.2M.
  • Bleichroeder added most to S&P Global in Q3 2026, an estimated $16M increase.
  • Bleichroeder's biggest Q3 2026 reduction was Opus Genetics, cutting an estimated $2.08M.
  • Bleichroeder fully exited Owlet in Q3 2026, selling an estimated $987K.
  • Bleichroeder's ten largest holdings make up 44% of its $1.02B portfolio in Q3 2026.
  • Bleichroeder opened 35 new positions and closed 3 in Q3 2026.
  • Bleichroeder's portfolio value rose 82% quarter-over-quarter to $1.02B.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.